LB210

Nebraska LB210 establishes fees for the prescription drug monitoring program and designated health information exchange.

Nebraska LB210 creates fees for participation and use of the prescription drug monitoring program and designated health information exchange. The bill outlines the information to be reported to the prescription drug monitoring system, including patient details, prescriber information, and prescription specifics. It mandates that health care facilities and health insurance plans participate in the designated health information exchange. The bill also establishes the Population Health Information Assessment Fund to cover nonfederal costs and assessment collection costs.